AK138D1
- Generic Name
- AK138D1
A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors
- First Posted Date
- 2024-12-12
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Akeso
- Target Recruit Count
- 100
- Registration Number
- NCT06730386
- Locations
- 🇦🇺
Blacktown Hospital-Blacktwon Cancer and Haematology Centre, Blacktown, New South Wales, Australia
🇦🇺Macquarie University, North Ryde, New South Wales, Australia
🇦🇺ICON Cancer Centre South Brisbane, South Brisbane, Queensland, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath